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Abstract
Background: Chromosome 9p21 has recently been shown to be a risk region for a broad range of vascular diseases. Since
carotid intima-media thickness (IMT) and plaque are independent predictors for vascular diseases, the association between
9p21 and these two phenotypes was investigated.
Methodology/Principal Findings: Carotid segment-specific IMT and plaques were obtained in 1083 stroke- and myocardial
infarction-free volunteers. We tested the genotypes and haplotypes of key single nucleotide polymorphisms (SNPs) on
chromosome 9p21 for the associations with carotid IMT and plaque. Multivariate permutation analyses demonstrated that
carriers of the T allele of SNP rs1333040 were significantly associated with thicker common carotid artery (CCA) IMT
(p=0.021) and internal carotid artery (ICA) IMT (p=0.033). The risk G allele of SNP rs2383207 was associated with ICA IMT
(p=0.007). Carriers of the C allele of SNP rs1333049 were found to be significantly associated with thicker ICA IMT (p=0.010)
and the greater risk for the presence of carotid plaque (OR=1.57 for heterozygous carriers; OR=1.75 for homozygous
carriers). Haplotype analysis showed a global p value of 0.031 for ICA IMT and 0.115 for the presence of carotid plaque.
Comparing with the other haplotypes, the risk TGC haplotype yielded an adjusted p value of 0.011 and 0.017 for thicker ICA
IMT and the presence of carotid plaque respectively. Further analyzing the data separated by sex, the results were
significant only in men but not in women.
Conclusions: Chromosome 9p21 had a significant association with carotid atherosclerosis, especially ICA IMT. Furthermore,
such genetic effect was in a gender-specific manner in the Han Chinese population.
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Introduction
A recent discovery has noted that variation of single nucleotide
polymorphisms (SNPs) on chromosome 9p21 is highly associated
with the risk of coronary artery disease (CAD) and myocardial
infarction (MI) [1,2,3]. Similarly, this risk region has also been
demonstrated to be significantly associated with the atherosclerotic
stroke subtype [4]. Given that atherosclerosis is considered as the
pathology underlying the majority of CAD and atherosclerotic
stroke, it is reasonable to consider that atherosclerosis is one of the
mechanisms for 9p21-related events.
Carotid intima-media thickness (IMT) and plaque have been
shown to be good subclinical atherosclerotic markers and
independent predictors for future cardiovascular events [5,6].
Despite both phenotypes correlate well to the pathology and
clinically defined atherosclerosis, they represent distinct traits [7].
It has been proposed that IMT changes reflect an adaptive process
and represent as an early carotid atherosclerosis, while plaque
formation may reflect a more significant alteration in vessel wall
and represent an estimate of more advanced status [8,9]. Thus,
these two aspects of atherosclerosis measures assay different
biological aspects of atherogenesis. Recently, there is evidence that
carotid IMT and plaque are largely controlled by genetics with
heritability estimates ranged from 30%–60% for IMT [10,11] and
about 28% for carotid plaque [12,13]. Therefore, both IMT and
plaque can be used as independent and compensatory surrogate
markers for genetic studies of atherosclerosis.
To date, only few studies have investigated the association of
this newly identified risk 9p21 locus with carotid atherosclerosis. In
a recent study recruiting subjects from the Atherosclerosis Risk in
Communities (ARIC) Study, the sequence variation on chromo-
some 9p21 was associated with carotid atherosclerosis risk among
whites but not in African-American population [14]. In a
population-based, prospective, Italian study, the variant alleles
on 9p21 were not only found to influence the development but
also the progression of carotid atherosclerosis [15]. However,
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study [17] demonstrated no association between the variant alleles
and burden of carotid atherosclerosis. Yet, replication studies in
other populations, such as Asians, would be warranted.
Therefore, we conducted a study using a stroke- and MI- free
Han Chinese population resided at southern Taiwan to evaluate
the risk of chromosome 9p21 for pre-clinical atherogenic
phenotypes, including IMT and plaque formation. As sex may
contribute to the genetic predisposition [14,18], sex-specific effect
of chromosome 9p21 was also tested.
Results
Among the 1083 stroke- and MI-free participants, carotid IMT
data are available for 1074 subjects, plaque index data for 810
subjects and both sets of data for 801subjects. The clinical,
demographic and ultrasonic data are shown in Table 1. The mean
and SD of age was 52.16 6 11.79 years (range from 21–87 years).
Men accounted for 45.8% of the total population. Men had
significantly thicker carotid IMT in all three segments
(p=3.33610
27 for common carotid artery (CCA); p=1.83610
28
for bifurcation (Bif); and p=6.51610
217for internal carotid artery
(ICA)) and greater risk for the presence of carotid plaque
(p=1.45610
25) than women (Table 1). The genotype distributions
of the four selected SNPs (rs1333040, rs2383207, rs10757278, and
rs1333049) did not deviate from Hardy-Weinberg equilibrium
(HWE). All four SNPs were in the same linkage disequilibrium (LD)
block (Figure S1). Two SNPs (rs10757278 and rs1333049) had high
r
2 of 0.95 and thus only rs1333049 was presented hereafter.
Associations of the three SNPs with carotid IMT and plaque are
shown in Table 2 and Table 3 respectively. Only adjusted
permutation p values are presented. Carriers of the T allele of SNP
rs1333040 had a significantly higher IMT at the segment of CCA
IMT (p=0.021) and ICA IMT (p=0.033). Carriers of the G allele
of SNP rs2383207 had higher ICA IMT (p=0.007). For the SNP
rs1333049, risk C allele was significantly associated with higher
ICA IMT (p=0.010). Of the tested SNPs, only rs1333049 showed
significant association with the presence of carotid plaque. Subjects
with the GC genotype of rs1333049 had a 1.57-fold
(95%CI=1.06–2.33; p=0.024) risk for the presence of carotid
plaque, compared with those with the GG genotype. Similarly, the
CC genotype frequency in the carotid plaque group was higher
(adjusted OR=1.75, 95%CI=1.12–2.75; p=0.015) than GG
genotype.
To examine the sex-specific effect, we further elucidated the
above significant associations of candidate SNPs and atheroscle-
rosis phenotypes by sex stratification. Sex-specific analysis showed
that the significant association only existed in men and no
significant associations were observed in women (Table 4). Men
carrying the risk T allele of SNP rs1333040 had thicker IMT at the
CCA (p=0.015) and ICA (p=0.012) segments. The G allele of
rs2383207 was associated with increased ICA IMT (p=0.004).
Similarly, the C allele of rs1333049 was also shown to be related
with ICA IMT (p=0.002) and the presence of carotid plaque.
Among the male subjects, the OR (95% CI) for the presence of
carotid plaque were 1.87 (1.01–3.56) for the GC genotype and
2.45 (1.22–5.01) for the CC genotype compared with the GG
genotype. In addition to stratifying the data by sex, the above
significant associations was re-examined in a regression model to
exam the interaction between sex and genotypes. There was a
borderline interaction effect between sex and rs1333040 for CCA
IMT (p=0.060); while significant interaction effects between sex
and rs2383207 (p=0.044), sex and rs1333049 (p=0.016) for ICA
IMT. However, for the carotid plaque, the number of cases in the
presence of carotid plaque group was relatively small (for example,
only 134 men had plaque) and the interaction difference for
rs1333049 did not reach statistical significance (p=0.540).
Further, the interaction by sex might be potentially confounded
by smoking for the most current smokers are males in this study.
However, there was no statistical difference between smoking and
Table 1. Characteristics of the study participants.
All Men Women
N=1083 N=496 N=587
n (%) or mean± SD p-value (men vs. women)
Age, yr 52.16611.79 52.31612.16 52.02611.48 0.68
Hypertension 287 (26.50) 135 (27.22) 152 (25.89) 0.62
Diabetes 86 (7.97) 50 (10.10) 36 (6.16) 0.02
Hypercholesterolemia 175 (16.23) 80 (16.16) 95 (16.27) 0.96
Body mass index 24.2563.49 25.0963.24 23.5363.55 5.35610
213
Current smoker 106 (10.02) 98 (20.29) 8 (1.39) 2.03610
224
Carotid IMT n=1074 n=490 n=584
CCA (mm) 0.6160.14 0.6360.16 0.5960.12 3.33610
27
Bif (mm) 0.6460.13 0.6760.14 0.6260.12 1.83610
28
ICA (mm) 0.5060.10 0.5360.11 0.4860.08 6.51610
217
Carotid plaque n=810 N=323 N=487
No plaque 534 (65.9%) 189 (58.5%) 345 (70.8%) 1.45610
25
Any plaque 276 (34.1%) 134 (41.5%) 142 (29.2%)
IMT: intima-media thickness.
CCA: common carotid artery.
Bif: bifurcation.
ICA: internal carotid artery.
doi:10.1371/journal.pone.0015124.t001
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by smoking (data not shown).
The association of haplotypes comprising these three SNPs
(rs1333040, rs2383207 and rs1333049) was further investigated.
The global p values were 0.031 for ICA IMT and 0.115 for the
presence of plaque. As compared with other haplotypes, the risk
TGC haplotype had a higher risk for ICA IMT and the presence
of carotid plaque with an adjusted p value of 0.011 and 0.017
respectively in overall study subjects. The data were then re-
analyzed by sex stratification. For men, the global p values were
0.028 for ICA IMT and 0.028 for the presence of plaque. The risk
TGC haplotype was significantly associated with ICA IMT
(adjusted p=0.007, beta coefficient=0.01) and the presence of
carotid plaque (adjusted p=0.012, OR=1.57) in males. However,
no individual haplotype was significantly associated with carotid
IMT or plaque in female subjects.
Discussion
In this study, we investigated the relationship between SNPs at
chromosome 9p21 and carotid atherosclerosis measured as carotid
IMT and plaque. We found that (1) SNPs at this region were
associated with both atherosclerotic traits; (2) the genetic effect of
9p21 was only found in men but not in women, and (3) the genetic
association was found on IMT at both CCA and ICA segments,
especially at ICA. Given that atherosclerosis is a common
pathogenesis underlying the majority of CAD and stroke, our
findings provide additional insight to understand the mechanistic
basis of 9p21 on these clinical consequences.
Different atherosclerosis phenotypes have been used for
evaluating the association of 9p21 in the carotid artery, including
IMT [14,15,16,17], stenosis [15], and plaque [15]. The previous
relevant studies and ours were summarized in Table 5. The
Finnish study included two population-based cohorts of different
age groups (2277 individuals between 24–39 years old and 1295
individuals between 46–76), and found no evidence of an
association between rs1333049 and CCA IMT in either cohort
[16]. Another study enrolling 1425 members of 248 Caucasian
families ascertained through a hypertensive proband also failed to
provide the evidence of association between four 9p21SNPs
(rs1333049, rs7044859, rs496892 and rs7865618) and CCA IMT
[17]. In contrast, a data analysis of the ARIC Study revealed an
association between SNP rs10757274 (r
2= 0.91 with rs1333049 in
the HapMap [19] Chinese samples) and carotid atherosclerosis in
the 11085 white subjects but not in the 4018 African-American
participants [14]. However, the definition of carotid atherosclero-
sis in this study was mixed phenotypes, as high IMT (mean of
CCA, ICA and bifurcatin IMT .1.0 mm) or the presence of
carotid plaque. With mean IMT (i.e. combined CCA, ICA and
bifurcation IMT), no significant association was found in this study
Table 2. Association of chromosome 9p21 SNPs with carotid intima-media thickness (IMT) (n=1074).
IMT, Mean±SD (mm) p* value
rs1333040 CC (n=99) CT (n=436) TT (n=516)
CCA IMT 0.6060.11 0.6060.13 0.6260.15 0.021
Bif IMT 0.6360.11 0.6460.12 0.6560.14 0.125
ICA IMT 0.5060.08 0.4960.09 0.5160.11 0.033
rs2383207 AA (n=136) AG (n=460) GG (n=454)
CCA IMT 0.6160.12 0.6060.14 0.6160.15 0.192
Bif IMT 0.6460.11 0.6460.12 0.6560.14 0.117
ICA IMT 0.4960.08 0.4960.09 0.5160.11 0.007
rs1333049 GG (n=311) GC (n=493) CC (n=255)
CCA IMT 0.6160.13 0.6160.14 0.6160.15 0.592
Bif IMT 0.6460.11 0.6460.14 0.6560.14 0.536
ICA IMT 0.4960.09 0.5060.09 0.5160.12 0.010
*Permutation p value after being adjusted for age, sex, hypertension, diabetes, hypercholesterolemia, body mass index and current smoking.
CCA: common carotid artery.
Bif: bifurcation.
ICA: internal carotid artery.
doi:10.1371/journal.pone.0015124.t002
Table 3. Genotype distribution of chromosome 9p21 SNPs
according to carotid plaque status (n=810).
SNP/
genotype Carotid plaque, N (%) OR (95%CI) p* value
No plaque Any plaque
rs1333040
CC 48 (9.21) 22 (8.03) 1.00
CT 225 (43.19) 103 (37.59) 1.06 (0.58–1.93) 0.849
TT 248 (47.60) 149 (54.38) 1.39 (0.78–2.55) 0.274
rs2383207
AA 72 (13.87) 29 (10.66) 1.00
AG 222 (42.77) 118 (43.38) 1.40 (0.84–2.39) 0.179
GG 225 (43.35) 125 (45.96) 1.56 (0.93–2.67) 0.071
rs1333049
GG 166 (31.62) 65 (23.72) 1.00
GC 238 (45.33) 136 (49.64) 1.57 (1.06–2.33) 0.024
CC 121 (23.05) 73 (26.64) 1.75 (1.12–2.75) 0.015
*Permutation p value after being adjusted for age, sex, hypertension, diabetes,
hypercholesterolemia, body mass index and current smoking
doi:10.1371/journal.pone.0015124.t003
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Men Women
b value p* value b value p* value
CCA IMT{ n=490 n=584
rs1333040 (T){ 0.022 0.015 0.004 0.519
ICA IMT{
rs1333040 (T){ 0.019 0.012 0.002 0.642
rs2383207 (G){ 0.021 0.004 0.003 0.487
rs1333049 (C){ 0.022 0.002 0.001 0.815
Any vs. no plaque n=134 vs. 189 n=142 vs. 345
OR (95%CI) p* value OR (95%CI) p* value
rs1333049
GG 1.00 1.00
GC 1.87 (1.01–3.56) 0.051 1.36 (0.83–2.27) 0.228
CC 2.45 (1.22–5.01) 0.013 1.36 (0.75–2.47) 0.318
*permutation p value after being adjusted for age, hypertension, diabetes, hypercholesterolemia, body mass index and current smoking.
{The IMT was measured as a continuous variable.
{Parentheses represented the risk allele of candidate SNPs.
CCA: common carotid artery; ICA: internal carotid artery.
doi:10.1371/journal.pone.0015124.t004
Table 5. Relevant studies of polymorphisms at 9p21 and carotid atherosclerosis.
Study
population
Study design, sample size,
Age (range or mean±SD) Study SNPs Phenotypes Findings
Italian [15] Prospective*, n=769,
age: 40–79
rs1333049,
rs10757274
1. Atherosclerosis progression1; 1. Significant results in all phenotypes
except for CCA IMT;
2. Incident stenosis.40%; 2. No gender specific effect
3. Atherosclerosis score{;
4. CCA IMT
Finnish [16] Two cohorts: Young Finns
Study (n=2277, age: 24–39);
Health 2000 cohort (n=1295,
age: 46–76)
rs1333049 CCA IMT No association in either cohort
British [17] Family members of
hypertensive probands,
n=1425, mean
age:49.56 15.5
rs1333049,
rs7044859,
rs496892,
rs7865618
CCA IMT No association
White and African-
Americans [14]
African-American (n=4018);
White American (n=11085);
overall age: 45–64
rs10757274,
rs2383206
1. Mean IMT (i.e. combined
CCA, Bif and ICA IMT);
1. No associations for mean IMT;
2. Carotid atherosclerosis{ 2. Significant association for carotid atherosclerosis
among white but not in African-Americans
Chinese (the present
study)
healthy volunteers,
n=1083, age: 21–87
rs1333040,
rs2383207,
rs1333049,
rs10757278
1. Different segment IMT over
CCA, Bif, ICA;
1. Significant association for CCA and ICA IMT,
more prominent at ICA segment;
2. Carotid plaque 2. Significant association for carotid plaque;
3. Gender specific effect: only in men, not in
women
IMT: intima-media thickness, CCA: common carotid artery, Bif: bifurcation, ICA: internal carotid artery.
*Phenotypes follow-up in the 1990, 1995 and 2000.
1Atherosclerosis progression: defined by the occurrence of atherosclerotic lesions in segments previously free of atherosclerosis or relative increase in the plaque
diameter.
{Atherosclerosis score: calculated by summing the diameter of plaques at 8 locations, including bilateral proximal and distal segments of CCA and ICA.
{carotid atherosclerosis: high IMT (mean of CCA, ICA and bifurcatin IMT .1.0 mm) or the presence of carotid plaque.
doi:10.1371/journal.pone.0015124.t005
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9p21 on carotid atherosclerosis in Asians. The genetic variation in
our study is associated with a risk for increased CCA, ICA IMT
and carotid plaque. Leading explanations for these discrepant
findings include the presence of undetected population stratifica-
tion at 9p21 as well as differences of races, environment and the
method to assess the carotid atherosclerosis, especially on the
segment of IMT measurement. Population stratification is unlikely
as an explanation for our case-control association result since we
have tested for it in part of our cohort and no detectable
population stratification was found [20].
It is suggested that each carotid artery segment could be
influenced by different sets of genes [21] and be prone to variant
pathophysiologic mechanisms [22]. Moreover, atherosclerosis at
different carotid artery segment was demonstrated to have variant
prediction of clinical cardiovascular events [5]. This present study
was assessed the relationship between chromosome 9p21 genetic
variants and each carotid segment IMT. The results indicated that
9p21 was associated with IMT at both segments of CCA and ICA,
and this relationship is particularly pronounced at ICA segment.
The ICA IMT was thought to be a better predictor of MI then
CCA IMT or the combined CCA, ICA measure [5]. This finding
provided more understanding the mechanism of 9p21 in CAD
risk.
Atherosclerosis can be viewed as a gradual process from
thickening of IMT to plaque formation. In contrast with carotid
IMT, the relation between carotid plaque and chromosome 9p21
was seldom studied except for one recent report [15]. Consistent
with our findings, that study showed the association of the
rs1333049 SNP with the severity of atherosclerosis score
(calculated by summing the maximum diameter of CCA, ICA
plaques) [15]. This present study successfully demonstrated a
relationship between 9p21 and both carotid atherosclerotic
phenotypes, indicating the contribution of the risk gene variants
in both early and late stages of atherogenesis. This data, along with
prior studies demonstrated the associations between this risk
genetic region and progression of atherosclerosis [15], abdominal
aortic and cerebral aneurysms [23,24], implicate that the
mechanism of this genetic effect on the vascular wall is more
complex and could influence various vascular pathogenesis.
A sex-differential relationship seen in this study is similar to the
association between heart failure and SNP rs10757274 at 9p21
[14] and that between SNP rs10757274 and abdominal aorta
stiffness [18], both in men only. A possible biological explanation
is that sex hormones may regulate the expression of these
candidate genes [25]. To test if the gene-estrogen interaction is
involved, female subjects were stratified by the menopausal status
for further analysis. The absence of significant difference between
carotid atherosclerosis and the three SNPs at 9p21 in either strata
(Tables S1–S2) indicated the lack of association in women was not
related to the menopausal status. Since the chromosome 9p21
region has been related to increased risk for MI in both men and
women, the genetic effect on women may demonstrate in other
intermediate phenotypes rather than carotid IMT or plaque.
Further studies are warranted to elucidate the molecular
mechanism of 9p21 in women.
There are strengths and limitations in the present study. The
chromosome 9p21 association studies have mainly been done in
the Caucasian populations and our study is the first to show its
relationship in the Asian population and also the sex-specific effect.
Our IMT was measured in the plaque free region, therefore, the
genetic association for plaque and IMT would not be confounded
by the measurement issue. Since our recruited participants were
free of MI and stroke, the interpretation of these results can be
expanded to the general population although it may not be
applicable to high risk populations such as diabetic subjects.
In conclusion, our work suggests that the chromosome 9p21 had
a significant association with carotid atherosclerosis, especially
ICA IMT. Among the Han Chinese population, the genetic effect
was primary found in men but not in women.
Methods
Ethics Statement
This study was approved by the Institutional Review Board of
Kaohsiung Medical University Hospital. All participants provided
written informed consent.
Study Subjects
Subjects were recruited between January 2006 and December
2008 with an advertisement solicitation at the Kaohsiung Medical
University Hospital. After excluding volunteers with a history of
stroke (n=29) and MI (n=10), a total of 1083 stroke- and MI- free
participants were included.
Each participant filled a self-administered questionnaire which
includes sociodemographic information, medical history and
medication data. Total cholesterol, triglycerides, and glucose
levels were measured from venous blood after fasting for at least
8 hours. Hypertension was defined as systolic or diastolic blood
pressure $140/90 mm Hg, or under anti-hypertensive medica-
tions. Diabetes was defined as fasting blood glucose $126 mg/dl
or known treatment for diabetes. Hypercholesterolemia was
defined as serum levels of total cholesterol $240 mg/dl.
Carotid ultrasongraphy studies
IMT measurement. Carotid IMT was assessed using Philips
HD 11 ultrasonography system equipped with a broadband linear
array 3,12-MHz transducer. All ultrasound measurements were
conducted by a experienced technologist who was blind to the
patients’ clinical data. The far wall of carotid IMT was visualized
bilaterally and IMT was measured at plaque-free area of CCA
(10–20 mm proximal to the tip of the flow divider), Bif (tip of the
flow divider and extending 10 mm proximally) and ICA (proximal
10 mm above the bulb) separately. The carotid IMT was analyzed
by the off-line automatic computerized analyzing system (Philips
Qlab quantification software). Mean IMT values of both right and
left arteries from each segment were taken for analyses. The intra-
reader absolute IMT difference and standard deviation (SD)
between two readings was 0.0160.01 mm in CCA, 0.036
0.04 mm in Bif and 0.0260.01 mm in ICA.
Carotid plaque measurement. Carotid plaque, defined as
an area of focal protrusion into the lumen at least 50% greater
than the surrounding wall thickness, was assessed by the same
equipment used in carotid IMT measurement. Presence of carotid
plaques at 10 locations in the carotid arteries (proximal and distal
CCA, Bif, ICA and external carotid artery) was recorded. The
carotid plaque reading protocol was performed offline and all the
ultrasonic data were read by a single neurologist (HFL).
Genotyping
Genomic DNA was isolated from whole blood using a
commercial available kit (Puregene from Gentra, Research
Triangle, NC). Four SNPs (rs10757278, rs2383207, rs1333040
and rs1333049) at chromosome 9p21 were selected on the basis of
previous studies consistently reporting as key SNPs to CAD and
stroke [1,3,26]. Genotypes were determined using TaqMan
technology (Applied Biosystems, Foster City, California). The
Chromosome 9p21 and Subclinical Atherosclerosis
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98.7%.
Statistical analysis
Allele frequencies at each SNP were estimated by direct
genotypes counting. HWE was tested for the relationship between
allele and genotype frequencies by using the x
2 test. HWE states
both allele and genotype frequencies in a population remain
constant. Deviated from the HWE can cause false positive of
observed association in the data. The LD, which is a phenomenon
whereby genetic variants are associated, between the tested SNPs
was calculated by the Haploview software (version 4.2) [27]. We
assumed an additive model in the present analyses. The
associations of genotypes with carotid IMT were analyzed by
multivariate regression models with adjustment for conventional
risk factors (age, sex, diabetes, hypertension, current smoking,
body mass index and hypercholesterolemia). For carotid plaque,
logistic regression analysis was used to evaluate the difference of
genotype distribution between with and without plaque group. To
assess the sex-specific effect, we analyzed male and female data
separately and further confirmed in the regression model by
adding an interaction variable (genotypes*sex) with adjustment for
conventional risk factors.
The package Hap-Clustering of R software (version 2.9.0) [28]
was used to test for the haplotype-phenotype association. The
haloptype global p value was obtained by evaluating the frequencies
of overall possible haplotypes between cases and controls; whereas
the haplotype-specific p value was for a particular haplotype
between cases and controls. Multiple testing corrections were
performed using the max (T) permutation procedure for 10,000
times to obtain empirical p value by the PLINK software [29]. A
two-tailed P value less than 0.05 was considered statistically
significant. Statistical analyses were performed with the SPSS 12.0
software (SPSS Inc., Chicago, Illinois, USA).
Supporting Information
Figure S1 Analysis of linkage disequilibrium (LD).
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Table S1 Chromosome 9p21 SNPs with carotid IMT/
plaque in women without menopause.
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Table S2 Chromosome 9p21 SNPs with carotid IMT/
plaque in women with menopause.
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